Neural antibodies can specifically label and recognize molecules on nerve cells, enabling a more comprehensive understanding and study of the biological properties, functions, and mechanisms of nerve cells in neurodegenerative diseases.
Covering iPSC neural cells, brain organoids, and microelectrode array services, our tools support neural development, disease modeling, and drug screening with high quality and reliable performance to meet diverse research needs.
Name:Toll like receptor 2 Target Synonym:CD282,Toll-like receptor 2,TIL4,Toll/interleukin-1 receptor-like protein 4,TLR2,Toll Like Receptor 2,CD282 Antigen,EC:3.2.2.6
Number of Launched Drugs:1 Number of Drugs in Clinical Trials:5 Lastest Research Phase:Phase 2 Clinical
Product Inquiry
* We couldn't find what you're looking for. You can let us help by filling the form below. Our
tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information
will be kept strictly confidential.
Synonym Name
Background
Toll-like receptors (TLRs) take key roles in the host immune response and are swiftly activated by infection or other types of immunological stress. Toll-like receptor 2 (TLR2) is indicated to initiate the activation of NLRP3 inflammasome and might involve in asthma. Additionally, further research uncovered that Wnt5a is also a direct ligand of toll-like receptor (TLR) 2 and 4 might affect the typical pattern recognition receptor-induced innate immune response genes.
Clinical and Translational Updates
This web search service is supported by Google Inc.